MYKRONOZ
On the sidelines of a downsized Baselworld 2018, MyKronoz , the premier watchmaking brand of the smart generation today announces record-breaking crowdfunding results of its hybrid smartwatch ZeTime , with more than $8,000,000 raised in less than a year. The international success of its unique and groundbreaking flagship wearable is followed by the release of a new digital video campaign “I’m a watch; I’m a smartwatch”.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180322005963/en/
After a historic 35-days Kickstarter campaign launched in March 2017, ZeTime has pursued, since then, its crowdfunding journey on a variety of international and local platforms: Indiegogo , Makuake in Japan, Zec Zec in Taïwan, Wadiz in Korea and on the leading chinese e-commerce website JD.com . Further to this online momentum, MyKronoz has successfully shipped to over 100 countries close to 40,000 backers, who are proudly wearing their hybrid smartwatch everyday. In addition, ZeTime is now available on Amazon as well as at the most prestigious offline retailers worldwide.
“With ZeTime, we managed to create a new standard: the one and only hybrid wearable device that perfectly reconciles traditional watch lovers and connected devices’ intenders” said Boris Brault, CEO of MyKronoz. He adds: “Our strong electronic background combined with our Swiss DNA gives us a significant advantage over the watch and wearables industries to develop consumer centric and nicely designed products. In a context of uncertainty weighting on the watch market, and although most of the wearable makers are not attending this year Baselworld, I strongly believe we are developing the right strategy. Combining design, features and affordable prices to ensure our company growth and acquire a leadership position.”
The young Swiss challenger to reaffirm its willingness to disrupt a well-established industry, puts the consumer at the center of its product development and innovation strategy while learning from the weaknesses of the traditional watchmakers.
To increase consumer engagement and worldwide brand awareness, MyKronoz just released the fun “I’m a watch; I’m a smartwatch” video series. Debuting this week on social platforms, the 6 episodes portray two rival quirky characters who respectively personify the watch and the smartwatch.
About ZeTime:
The world's first hybrid smartwatch with
mechanical hands over a color touchscreen, ZeTime
offers the classic design of a Swiss timepiece with most advanced
features of a smartwatch. MyKronoz’s proprietary ‘Smart Movement’
technology enables ZeTime’s always-on hands to function for up to 30
days with a single charge, ensuring the primary function of the watch –
to tell time – is always running. With a retail price starting at $199,
the hybrid device is available in two different case sizes (39mm and
44mm) and displays (1.05 inch and 1.22-inch). ZeTime boasts three
collections comprising a variety of watch case finishing and bands, to
appeal to a wide audience.
With $8M raised in crowdfunding, MyKronoz and ZeTime have become the most funded European company in Kickstarter history, most funded hybrid smartwatch and product of 2017.
About us:
Founded in January 2013, MyKronoz
is a Swiss company headquartered in Geneva that designs and develops
wearable devices to expand and facilitate the connected experience of
the smart generation. Bringing together the essence of watchmaking
tradition with innovative technology, MyKronoz offers a full range of
affordable and stylish wearables, starting at a price point of $39 only,
spanning across 4 product categories: activity trackers, smartwatches,
hybrid smartwatches and watch phones, all compatible with iOS and
Android.
Present in more than 40 countries, carried by major
retailers and partners worldwide (Orange, Auchan, Carrefour, Amazon,
Best Buy...), MyKronoz has sold more than 3 million products and
established itself as a fierce challenger to both tech and traditional
watchmakers.
MyKronoz is part of BOW Group , a global player in the Internet of Things (IoT), operating worldwide in the wearables, connected vehicles and smart home markets. In July 2015, BOW raised €10 million from NextStage AM in series A funding round and closed in November 2017 its $23.5 million series B funding lead by PM Equity Partner , the corporate venture fund of Philip Morris International.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180322005963/en/
Contact:
MyKronoz
Media:
Annabel Corlay
press@mykronoz.com
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
A-CAP Announces Successful Divestiture of Standard de Liège SA and Immobilière du Standard de Liège SRL6.6.2025 22:32:00 CEST | Press release
Successful Transaction Marks Another Milestone in A-CAP’s Soccer Club Portfolio Strategy Advantage Capital Holdings, LLC (“A-CAP” or “The Company”), a New York-based insurance and financial services company with over $12 billion in assets, today announced the successful divestiture of Standard de Liège SA (“Standard Liège” or the “Club”), one of Belgium's most historic soccer clubs, and Immobilière du Standard de Liège SRL, the corporate entity that owns the Club's stadium, Maurice Dufrasne Stadium, to a consortium of buyers led by Standard Liège Chief Executive Officer Giacomo Angelini. This transaction marks the end of 777 Partners’ legacy involvement with the Club and sets the stage for the Club’s future growth and success, both on and off the field. Benefits of the transaction include: Increased stability across the Club’s shareholder base, which clears the path for future investments, Operational clarity, establishing a unified direction that will allow both players and management
Populous Acquires Fentress Architects, Expanding Global Aviation Portfolio6.6.2025 20:00:00 CEST | Press release
Populous, the world-renowned design firm specializing in sport and entertainment venues, today announced the acquisition of Denver-based Fentress Architects, a global leader in iconic aviation projects and prominent public buildings, including convention centers, museums and government facilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606849000/en/ Los Angeles International Airport. Designed by Fentress Architects. This strategic acquisition unites two of the most respected names in architecture, combining Populous’ unparalleled expertise in designing memorable experiences with Fentress’ award-winning portfolio of aviation, civic and cultural landmarks. The acquisition significantly broadens the scope and scale of services that Populous can offer clients across the globe. Bruce Miller, Populous Global Chair and CEO, commented: “We are committed to expanding the breadth of our practice. Fentress Architects has lon
Vertex Presents New Data on Benefits of ALYFTREK® and Importance of Achieving Lower Sweat Chloride Levels at the European Cystic Fibrosis Conference6.6.2025 18:00:00 CEST | Press release
- Oral presentation on outcomes following treatment with CFTR modulators show that improvements in CFTR function, as measured by lower sweat chloride, correlate with better outcomes for people with cystic fibrosis - - Oral presentation on new post hoc data from randomized, controlled and open-label trials suggest improved quality of life results with ALYFTREK compared to TRIKAFTA® – Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data across multiple studies demonstrating positive clinical and quality of life benefits of treatment with CFTR modulators and, in particular, ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor), which is approved in the United States and United Kingdom and is currently under review with health authorities in the EU, Canada, Australia, New Zealand and Switzerland. These data were presented at this year’s European Cystic Fibrosis Society’s (ECFS) 48th European Cystic Fibrosis Conference held June 4-7, 2025, in Milan, Italy. During the conferenc
Andersen Consulting tilføjer dimension med David and Golyat6.6.2025 16:33:00 CEST | Pressemeddelelse
Andersen Consulting udbygger sin globale konsulentkapacitet gennem en samarbejdsaftale med David and Golyat, en filippinsk konsulentvirksomhed inden for digital strategi. Med et stærkt fokus på business intelligence, kundeindsigt og digital first-eksekvering arbejder David and Golyat med kunder på tværs af flere sektorer – herunder regeringer, udviklingsorganisationer og private virksomheder – for at skabe langsigtet værdi gennem datainformerede beslutninger. Miko David, administrerende partner i David and Golyat, siger: "Vi ser frem til samarbejdet med Andersen Consulting, da det er en milepæl i vores vækstforløb. Ved at kombinere vores ekspertise inden for digital strategi og Andersen Consultings globale platform er vi i stand til at levere endnu større værdi til kunder, der navigerer på komplekse markeder." "Dette samarbejde betyder, at vi kan tilføre en ekstra dimension til vores globale konsulentplatform," siger Mark L. Vorsatz, global bestyrelsesformand og administrerende direktø
IBSA Derma at IMCAS Asia 2025: spotlight on the future of aesthetic medicine in the 10th Anniversary Year of NAHYCO® Technology6.6.2025 16:00:00 CEST | Press release
IBSA Derma, the dermoaesthetic division of Swiss company IBSA, will participate in the 18th IMCAS Asia Congress in Bangkok, gathering over 3,000 professionals from across the region to explore the future of aesthetic and regenerative medicine.With the presence in the Congress and a dedicated scientific symposium, the company reaffirms its commitment to advancing bioremodeling approaches and promoting a holistic, science-driven vision of authentic beauty.This year marks a key milestone for IBSA Derma: 10 years of NAHYCO® Technology, a patented innovation in hyaluronic acid science that continues to shape the future of tissue regeneration. IBSA Derma – the dermoaesthetic division of IBSA – once again confirms its leadership in the international aesthetic medicine landscape by participating in the 18th edition of IMCAS Asia, taking place from June 6 to 8 in Bangkok, Thailand. With over 3,000 attendees expected, the event represents a key opportunity for physicians and experts to share the
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom